Sarri, Barbara
Chevrier, Véronique
Poizat, Flora
Heuke, Sandro
Franchi, Florence
De Franqueville, Louis
Traversari, Eddy
Ratone, Jean-Philippe
Caillol, Fabrice
Dahel, Yanis
Hoibian, Solène
Giovannini, Marc
de Chaisemartin, Cécile
Appay, Romain
Guasch, Géraldine
Rigneault, Hervé
Funding for this research was provided by:
Fondation Aix-Marseille Universite
Agence Nationale de la Recherche (ANR-11-IDEX-0001-02, ANR-IDEX-17-14-170228-15.28 CapoStromEx, ANR-10-INSB-04-01, ANR-11-INSB-0006, ANR-16-CONV-0001, ANR-21-ESRS-0002 IDEC, ANR-11-IDEX-0001-02, ANR-IDEX-17-14-170228-15.28 CapoStromEx, ANR-10-INSB-04-01, ANR-11-INSB-0006, ANR-16-CONV-0001, ANR-21-ESRS-0002 IDEC)
Institut National de la Santé et de la Recherche Médicale (22CP139-00)
H2020 Excellent Science (ICT 101016923 CRIMSON)
European Research Council (101052911 SpeckleCARS)
Institut National Du Cancer (2019-188, 2019-188)
Agence régionale de santé Provence-Alpes-Côte d’Azur
Article History
Received: 7 January 2024
Accepted: 21 May 2024
First Online: 28 June 2024
Change Date: 8 August 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s44303-024-00035-1
Competing interests
: The authors declare no competing interests.
: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of Institut Paoli-Calmettes. Rectal cancer tissue samples from adult patients used to derived tumoroids were approved by the Paoli-Calmettes Institute Strategic Orientation Committee (authorization TZ-cancers-IPC 2015-021). Informed consent was obtained from all subjects involved in the study.